» Articles » PMID: 12603311

Oxygen-dependent Regulation of Hypoxia-inducible Factors by Prolyl and Asparaginyl Hydroxylation

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 2003 Feb 27
PMID 12603311
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

To sustain life mammals have an absolute and continual requirement for oxygen, which is necessary to produce energy for normal cell survival and growth. Hence, maintaining oxygen homeostasis is a critical requirement and mammals have evolved a wide range of cellular and physiological responses to adapt to changes in oxygen availability. In the past few years it has become evident that the transcriptional protein complex hypoxia-inducible factor (HIF) is a key regulator of these processes. In this review we will focus on the way oxygen availability regulates HIF proteins and in particular we will discuss the way oxygen-dependent hydroxylation of specific amino acid residues has been demonstrated to regulate HIF function at the level of both protein stability and transcriptional potency.

Citing Articles

Differential but complementary roles of HIF-1α and HIF-2α in the regulation of bone homeostasis.

Lee S, Kim S, Park K, Lee G, Oh Y, Ryu J Commun Biol. 2024; 7(1):892.

PMID: 39039245 PMC: 11263705. DOI: 10.1038/s42003-024-06581-z.


Hyperbaric oxygen therapy: future prospects in regenerative therapy and anti-aging.

Gupta M, Rathored J Front Aging. 2024; 5:1368982.

PMID: 38757145 PMC: 11097100. DOI: 10.3389/fragi.2024.1368982.


The role of hypoxia on prostate cancer progression and metastasis.

Mohamed O, Tesen H, Hany M, Sherif A, Abdelwahab M, Elnaggar M Mol Biol Rep. 2023; 50(4):3873-3884.

PMID: 36787054 PMC: 10042974. DOI: 10.1007/s11033-023-08251-5.


Regulation of Transactivation at C-TAD Domain of HIF-1 by Factor-Inhibiting HIF-1 (FIH-1): A Potential Target for Therapeutic Intervention in Cancer.

Rani S, Roy S, Singh M, Kaithwas G Oxid Med Cell Longev. 2022; 2022:2407223.

PMID: 35592530 PMC: 9113874. DOI: 10.1155/2022/2407223.


Specific Inhibition of HIF Activity: Can Peptides Lead the Way?.

Mylonis I, Chachami G, Simos G Cancers (Basel). 2021; 13(3).

PMID: 33499237 PMC: 7865418. DOI: 10.3390/cancers13030410.